{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T02:29:02Z","timestamp":1770258542975,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04725-9","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T02:04:29Z","timestamp":1767837869000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between skeletal fractures and sleep medication in patients with chronic kidney disease"],"prefix":"10.1186","volume":"27","author":[{"given":"Chikao","family":"Onogi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihito","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Furuhashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eri","family":"Koshi-Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoichi","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"key":"4725_CR1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2188\/jea.10.79","volume":"10","author":"Y Doi","year":"2000","unstructured":"Doi Y, Minowa M, Okawa M, Uchiyama M. Prevalence of sleep disturbance and hypnotic medication use in relation to sociodemographic factors in the general Japanese adult population. J Epidemiol. 2000;10:79\u201386. https:\/\/doi.org\/10.2188\/jea.10.79.","journal-title":"J Epidemiol"},{"key":"4725_CR2","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1365-2125.2012.04418.x","volume":"77","author":"M Lader","year":"2014","unstructured":"Lader M. Benzodiazepine harm: how can it be reduced. Br J Clin Pharmacol. 2014;77:295\u2013301. https:\/\/doi.org\/10.1111\/j.1365-2125.2012.04418.x.","journal-title":"Br J Clin Pharmacol"},{"key":"4725_CR3","first-page":"214","volume":"13","author":"CE Griffin","year":"2013","unstructured":"Griffin CE, Kaye AM, Bueno FR, Kaye AD. Benzodiazepine pharmacology and central nervous system-mediated effects. Ochsner J. 2013;13:214\u201323.","journal-title":"Ochsner J"},{"key":"4725_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2165\/00023210-200418010-00004","volume":"18","author":"MJ Barker","year":"2004","unstructured":"Barker MJ, Greenwood KM, Jackson M, Crowe SF. Cognitive effects of long-term benzodiazepine use: a meta-analysis. CNS Drugs. 2004;18:37\u201348. https:\/\/doi.org\/10.2165\/00023210-200418010-00004.","journal-title":"CNS Drugs"},{"key":"4725_CR5","first-page":"225","volume":"162","author":"AM Holbrook","year":"2000","unstructured":"Holbrook AM, Crowther R, Lotter A, Cheng C, King D. Meta-analysis of benzodiazepine use in the treatment of insomnia. CMAJ. 2000;162:225\u201333.","journal-title":"CMAJ"},{"key":"4725_CR6","doi-asserted-by":"publisher","first-page":"825","DOI":"10.2165\/00023210-200317110-00004","volume":"17","author":"RG Cumming","year":"2003","unstructured":"Cumming RG, Le Couteur DG. Benzodiazepines and risk of hip fractures in older people: a review of the evidence. CNS Drugs. 2003;17:825\u201337. https:\/\/doi.org\/10.2165\/00023210-200317110-00004.","journal-title":"CNS Drugs"},{"key":"4725_CR7","doi-asserted-by":"publisher","first-page":"e0174730","DOI":"10.1371\/journal.pone.0174730","volume":"12","author":"K Donnelly","year":"2017","unstructured":"Donnelly K, Bracchi R, Hewitt J, Routledge PA, Benzodiazepines CB. Z-drugs and the risk of hip fracture: a systematic review and meta-analysis. PLoS One. 2017;12:e0174730. https:\/\/doi.org\/10.1371\/journal.pone.0174730.","journal-title":"PLoS One"},{"key":"4725_CR8","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00198-013-2446-y","volume":"25","author":"D Xing","year":"2014","unstructured":"Xing D, Ma XL, Ma JX, Wang J, Yang Y, Chen Y. Association between use of benzodiazepines and risk of fractures: a meta-analysis. Osteoporos Int. 2014;25:105\u201320. https:\/\/doi.org\/10.1007\/s00198-013-2446-y.","journal-title":"Osteoporos Int"},{"key":"4725_CR9","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1001\/archinte.164.14.1567","volume":"164","author":"AK Wagner","year":"2004","unstructured":"Wagner AK, Zhang F, Soumerai SB, Walker AM, Gurwitz JH, Glynn RJ, et al. Benzodiazepine use and hip fractures in the elderly: who is at greatest risk. Arch Intern Med. 2004;164:1567\u201372. https:\/\/doi.org\/10.1001\/archinte.164.14.1567.","journal-title":"Arch Intern Med"},{"key":"4725_CR10","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1007\/s00198-005-1903-7","volume":"16","author":"L Dukas","year":"2005","unstructured":"Dukas L, Schacht E, St\u00e4helin HB. In elderly men and women treated for osteoporosis a low creatinine clearance of <65 ml\/min is a risk factor for falls and fractures. Osteoporos Int. 2005;16:1683\u201390. https:\/\/doi.org\/10.1007\/s00198-005-1903-7.","journal-title":"Osteoporos Int"},{"key":"4725_CR11","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1046\/j.1532-5415.2003.51110.x","volume":"51","author":"RS Braithwaite","year":"2003","unstructured":"Braithwaite RS, Col NF, Wong JB. Estimating hip fracture morbidity, mortality and costs. J Am Geriatr Soc. 2003;51:364\u201370. https:\/\/doi.org\/10.1046\/j.1532-5415.2003.51110.x.","journal-title":"J Am Geriatr Soc"},{"key":"4725_CR12","doi-asserted-by":"publisher","first-page":"380","DOI":"10.7326\/0003-4819-152-6-201003160-00008","volume":"152","author":"P Haentjens","year":"2010","unstructured":"Haentjens P, Magaziner J, Col\u00f3n-Emeric CS, Vanderschueren D, Milisen K, Velkeniers B, et al. Meta-analysis: excess mortality after hip fracture among older women and men. Ann Intern Med. 2010;152:380\u201390. https:\/\/doi.org\/10.7326\/0003-4819-152-6-201003160-00008.","journal-title":"Ann Intern Med"},{"key":"4725_CR13","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/s0092-8674(00)80949-6","volume":"92","author":"T Sakurai","year":"1998","unstructured":"Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 1998;92:573\u201385. https:\/\/doi.org\/10.1016\/s0092-8674(00)80949-6.","journal-title":"Cell"},{"key":"4725_CR14","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/nrn2092","volume":"8","author":"T Sakurai","year":"2007","unstructured":"Sakurai T. The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat Rev Neurosci. 2007;8:171\u201381. https:\/\/doi.org\/10.1038\/nrn2092.","journal-title":"Nat Rev Neurosci"},{"key":"4725_CR15","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/s0092-8674(00)81973-x","volume":"98","author":"RM Chemelli","year":"1999","unstructured":"Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C, et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell. 1999;98:437\u201351. https:\/\/doi.org\/10.1016\/s0092-8674(00)81973-x.","journal-title":"Cell"},{"key":"4725_CR16","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/s0896-6273(03)00330-1","volume":"38","author":"JT Willie","year":"2003","unstructured":"Willie JT, Chemelli RM, Sinton CM, Tokita S, Williams SC, Kisanuki YY, et al. Distinct narcolepsy syndromes in orexin receptor-2 and orexin null mice: molecular genetic dissection of non-REM and REM sleep regulatory processes. Neuron. 2003;38:715\u201330. https:\/\/doi.org\/10.1016\/s0896-6273(03)00330-1.","journal-title":"Neuron"},{"key":"4725_CR17","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3389\/fnins.2013.00254","volume":"7","author":"AD Ramirez","year":"2013","unstructured":"Ramirez AD, Gotter AL, Fox SV, Tannenbaum PL, Yao L, Tye SJ, et al. Dual orexin receptor antagonists show distinct effects on locomotor performance, ethanol interaction and sleep architecture relative to gamma-aminobutyric acid-A receptor modulators. Front Neurosci. 2013;7:254. https:\/\/doi.org\/10.3389\/fnins.2013.00254.","journal-title":"Front Neurosci"},{"key":"4725_CR18","doi-asserted-by":"publisher","first-page":"179ra44","DOI":"10.1126\/scitranslmed.3005213","volume":"5","author":"JM Uslaner","year":"2013","unstructured":"Uslaner JM, Tye SJ, Eddins DM, Wang X, Fox SV, Savitz AT, et al. Orexin receptor antagonists differ from standard sleep drugs by promoting sleep at doses that do not disrupt cognition. Sci Transl Med. 2013;5:179ra44. https:\/\/doi.org\/10.1126\/scitranslmed.3005213.","journal-title":"Sci Transl Med"},{"key":"4725_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.5664\/jcsm.5382","volume":"12","author":"H Sun","year":"2016","unstructured":"Sun H, Palcza J, Card D, Gipson A, Rosenberg R, Kryger M, et al. Effects of suvorexant, an orexin receptor antagonist, on respiration during sleep in patients with obstructive sleep apnea. J Clin Sleep Med. 2016;12:9\u201317. https:\/\/doi.org\/10.5664\/jcsm.5382.","journal-title":"J Clin Sleep Med"},{"key":"4725_CR20","doi-asserted-by":"publisher","first-page":"zsaa123","DOI":"10.1093\/sleep\/zsaa123","volume":"43","author":"M K\u00e4rpp\u00e4","year":"2020","unstructured":"K\u00e4rpp\u00e4 M, Yardley J, Pinner K, Filippov G, Zammit G, Moline M, et al. Long-term efficacy and tolerability of lemborexant compared with placebo in adults with insomnia disorder: results from the phase 3 randomized clinical trial sunrise 2. Sleep. 2020;43:zsaa123. https:\/\/doi.org\/10.1093\/sleep\/zsaa123.","journal-title":"Sleep"},{"key":"4725_CR21","doi-asserted-by":"publisher","first-page":"e1918254","DOI":"10.1001\/jamanetworkopen.2019.18254","volume":"2","author":"R Rosenberg","year":"2019","unstructured":"Rosenberg R, Murphy P, Zammit G, Mayleben D, Kumar D, Dhadda S, et al. Comparison of lemborexant with placebo and zolpidem tartrate extended release for the treatment of older adults with insomnia disorder: a phase 3 randomized clinical trial. JAMA Netw Open. 2019;2:e1918254. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.18254.","journal-title":"JAMA Netw Open"},{"key":"4725_CR22","doi-asserted-by":"publisher","first-page":"765","DOI":"10.5664\/jcsm.8294","volume":"16","author":"P Murphy","year":"2020","unstructured":"Murphy P, Kumar D, Zammit G, Rosenberg R, Moline M. Safety of lemborexant versus placebo and zolpidem: effects on auditory awakening threshold, postural stability, and cognitive performance in healthy older participants in the middle of the night and upon morning awakening. J Clin Sleep Med. 2020;16:765\u201373. https:\/\/doi.org\/10.5664\/jcsm.8294.","journal-title":"J Clin Sleep Med"},{"key":"4725_CR23","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1080\/00325481.2020.1823724","volume":"133","author":"M Moline","year":"2021","unstructured":"Moline M, Zammit G, Yardley J, Pinner K, Kumar D, Perdomo C, et al. Lack of residual morning effects of lemborexant treatment for insomnia: summary of findings across 9 clinical trials. Postgrad Med. 2021;133:71\u201381. https:\/\/doi.org\/10.1080\/00325481.2020.1823724.","journal-title":"Postgrad Med"},{"key":"4725_CR24","doi-asserted-by":"publisher","first-page":"e0284726","DOI":"10.1371\/journal.pone.0284726","volume":"18","author":"R Yoshioka","year":"2023","unstructured":"Yoshioka R, Yamamoto S, Nakatani E. Effectiveness of suvorexant versus benzodiazepine receptor agonist sleep drugs in reducing the risk of hip fracture: findings from a regional population-based cohort study. PLoS One. 2023;18:e0284726. https:\/\/doi.org\/10.1371\/journal.pone.0284726.","journal-title":"PLoS One"},{"key":"4725_CR25","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/jgs.18068","volume":"71","author":"M Adomi","year":"2023","unstructured":"Adomi M, Maeda M, Murata F, Fukuda H. Comparative risk of fracture in community-dwelling older adults initiating suvorexant versus Z-drugs: results from life study. J Am Geriatr Soc. 2023;71:109\u201320. https:\/\/doi.org\/10.1111\/jgs.18068.","journal-title":"J Am Geriatr Soc"},{"key":"4725_CR26","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s40266-023-01033-5","volume":"40","author":"T Saito","year":"2023","unstructured":"Saito T, Nojiri S, Kasai T, Hiratsuka Y, Ishijima M, Daida H. Association between the use of suvorexant and hip fracture in older adults in Japan using a nationwide administrative claims database: a matched case-control study. Drugs Aging. 2023;40:439\u201347. https:\/\/doi.org\/10.1007\/s40266-023-01033-5.","journal-title":"Drugs Aging"},{"key":"4725_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1214\/09-STS313","volume":"25","author":"EA Stuart","year":"2010","unstructured":"Stuart EA. Matching methods for causal inference: a review and a look forward. Stat Sci. 2010;25:1\u201321. https:\/\/doi.org\/10.1214\/09-STS313.","journal-title":"Stat Sci"},{"key":"4725_CR28","doi-asserted-by":"publisher","first-page":"100458","DOI":"10.1016\/j.xkme.2022.100458","volume":"4","author":"LH Tan","year":"2022","unstructured":"Tan LH, Chen PS, Chiang HY, King E, Yeh HC, Hsiao YL, et al. Insomnia and poor sleep in CKD: a systematic review and meta-analysis. Kidney Med. 2022;4:100458. https:\/\/doi.org\/10.1016\/j.xkme.2022.100458.","journal-title":"Kidney Med"},{"key":"4725_CR29","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.2169\/internalmedicine.45.1826","volume":"45","author":"A Noda","year":"2006","unstructured":"Noda A, Nakai S, Soga T, Sugiura T, Iwayama N, Maeda K, et al. Factors contributing to sleep disturbance and hypnotic drug use in hemodialysis patients. Intern Med. 2006;45:1273\u201378. https:\/\/doi.org\/10.2169\/internalmedicine.45.1826.","journal-title":"Intern Med"},{"key":"4725_CR30","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.2215\/CJN.01340118","volume":"13","author":"R Yamamoto","year":"2018","unstructured":"Yamamoto R, Shinzawa M, Isaka Y, Yamakoshi E, Imai E, Ohashi Y, et al. Sleep quality and sleep duration with CKD are associated with progression to ESKD. Clin J Am Soc Nephrol. 2018;13:1825\u201332. https:\/\/doi.org\/10.2215\/CJN.01340118.","journal-title":"Clin J Am Soc Nephrol"},{"key":"4725_CR31","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.kint.2019.09.032","volume":"97","author":"H Motohashi","year":"2020","unstructured":"Motohashi H, Tahara Y, Whittaker DS, Wang HB, Yamaji T, Wakui H, et al. The circadian clock is disrupted in mice with adenine-induced tubulointerstitial nephropathy. Kidney Int. 2020;97:728\u201340. https:\/\/doi.org\/10.1016\/j.kint.2019.09.032.","journal-title":"Kidney Int"},{"key":"4725_CR32","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1159\/000489672","volume":"47","author":"SM Ott","year":"2018","unstructured":"Ott SM. Cortical or trabecular bone: what\u2019s the difference. Am J Nephrol. 2018;47:373\u201375. https:\/\/doi.org\/10.1159\/000489672.","journal-title":"Am J Nephrol"},{"key":"4725_CR33","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s11914-016-0319-y","volume":"14","author":"DM Cooper","year":"2016","unstructured":"Cooper DM, Kawalilak CE, Harrison K, Johnston BD, Johnston JD. Cortical bone porosity: what is it, why is it important, and how can we detect it. Curr Osteoporos Rep. 2016;14:187\u201398. https:\/\/doi.org\/10.1007\/s11914-016-0319-y.","journal-title":"Curr Osteoporos Rep"},{"key":"4725_CR34","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.cmet.2014.03.016","volume":"19","author":"W Wei","year":"2014","unstructured":"Wei W, Motoike T, Krzeszinski JY, Jin Z, Xie XJ, Dechow PC, et al. Orexin regulates bone remodeling via a dominant positive central action and a subordinate negative peripheral action. Cell Metab. 2014;19:927\u201340. https:\/\/doi.org\/10.1016\/j.cmet.2014.03.016.","journal-title":"Cell Metab"},{"key":"4725_CR35","doi-asserted-by":"publisher","first-page":"1071962","DOI":"10.3389\/fpsyt.2023.1071962","volume":"14","author":"M Takeshima","year":"2023","unstructured":"Takeshima M, Aoki Y, Ie K, Katsumoto E, Tsuru E, Tsuboi T, et al. Physicians\u2019 attitudes toward hypnotics for insomnia: a questionnaire-based study. Front Psychiatry. 2023;14:1071962. https:\/\/doi.org\/10.3389\/fpsyt.2023.1071962.","journal-title":"Front Psychiatry"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04725-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04725-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04725-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T12:30:30Z","timestamp":1770208230000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-025-04725-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4725"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04725-9","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"assertion":[{"value":"25 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and the database assessment was approved by the Ethics Committee of the International Review Board of Nagoya University Hospital (approval number: 2021\u20130350). The requirement for informed consent was waived because of the anonymity of the data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"95"}}